11/25/2025

Janusmed amning

Janusmed amning – Anakinra

Janusmed amning tillhandahåller generella rekommendationer om huruvida ett friskt fullgånget spädbarn kan ammas när modern använder olika läkemedel. Observera att prematura och/eller sjuka spädbarn alltid kräver särskilda överväganden. Om du inte är medicinskt utbildad, läs först vår information för patienter och allmänhet.

För att komma till startsidan för Janusmed amning och för att göra sökningar klicka här.

Tillbaka till index
2 2
2 2

Anakinra

Anakinra

Klass : 2

Visa all info

Skriv ut

Kontakta oss

  1. Berger CT, Recher M, Steiner U, Hauser TM. A patient's wish: anakinra in pregnancy. Ann Rheum Dis. 2009;68:1794-5.

  2. Youngstein T, Hoffmann P, Gül A, Lane T, Williams R, Rowczenio DM et al. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Rheumatology (Oxford). 2017;56:2102-2108.

  3. Youngstein T, Hoffmann P, Lane T, Williams R, Rowczenio D, Ozdogan H, et al. International experience of pregnancy outcomes in auto-inflammatory syndromes treated with Interleukin-1 inhibitors. Pediatric Rheumatology. 2015;13(S1):O67.

  4. Smith CJF, Chambers CD. Five successful pregnancies with antenatal anakinra exposure. Rheumatology (Oxford). 2018.

  5. Cerne Cercek A, Gomiscek Novak A, Trojner Bregar A, Avcin T, Kessel C, Thurner L et al. Anakinra during pregnancy and lactation for corticosteroid-dependant colchicine-resistant recurrent pericarditis in a patient with neutralizing anti-interleukin-1 receptor antagonist antibodies: a case report. Eur Heart J Case Rep. 2025;9(6):ytaf280.

  6. Anakinra use during pregnancy and lactation: A case report. Reprod Toxicol 2019;88:139–40. [Abstract]

  7. Negro E, Costedoat-Chalumeau N, Nivuori M, Gabiati C, Pallini G, Brucato A. Anakinra During Pregnancy in a Difficult to Treat Case of Recurrent Pericarditis. Can J Cardiol. 2023;39(8):1152-1153.

  8. Trotta L, Mascolo R, Mardygan V, Cercek AC, Claveau AM, Sicignano LL et al. Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series. Eur J Obstet Gynecol Reprod Biol. 2025;312:114553.

  9. Faure-Bardon V, Beghin D, Fautrel B, Latour M, Vauzelle C, Reinaud C et al. Exposure during pregnancy to Il-1 targeted therapies and pregnancy, fetal and neonatal outcomes: a study from the French Teratology Information Service. Rheumatology (Oxford). 2025.

  1. Berger CT, Recher M, Steiner U, Hauser TM. A patient's wish: anakinra in pregnancy. Ann Rheum Dis. 2009;68:1794-5.
  2. Youngstein T, Hoffmann P, Gül A, Lane T, Williams R, Rowczenio DM et al. International multi-centre study of pregnancy outcomes with interleukin-1 inhibitors. Rheumatology (Oxford). 2017;56:2102-2108.
  3. Youngstein T, Hoffmann P, Lane T, Williams R, Rowczenio D, Ozdogan H, et al. International experience of pregnancy outcomes in auto-inflammatory syndromes treated with Interleukin-1 inhibitors. Pediatric Rheumatology. 2015;13(S1):O67.
  4. Smith CJF, Chambers CD. Five successful pregnancies with antenatal anakinra exposure. Rheumatology (Oxford). 2018.
  5. Cerne Cercek A, Gomiscek Novak A, Trojner Bregar A, Avcin T, Kessel C, Thurner L et al. Anakinra during pregnancy and lactation for corticosteroid-dependant colchicine-resistant recurrent pericarditis in a patient with neutralizing anti-interleukin-1 receptor antagonist antibodies: a case report. Eur Heart J Case Rep. 2025;9(6):ytaf280.
  6. Anakinra use during pregnancy and lactation: A case report. Reprod Toxicol 2019;88:139–40. [Abstract]
  7. Negro E, Costedoat-Chalumeau N, Nivuori M, Gabiati C, Pallini G, Brucato A. Anakinra During Pregnancy in a Difficult to Treat Case of Recurrent Pericarditis. Can J Cardiol. 2023;39(8):1152-1153.
  8. Trotta L, Mascolo R, Mardygan V, Cercek AC, Claveau AM, Sicignano LL et al. Use of anakinra during pregnancy and breastfeeding in women with recurrent pericarditis: A case series. Eur J Obstet Gynecol Reprod Biol. 2025;312:114553.
  9. Faure-Bardon V, Beghin D, Fautrel B, Latour M, Vauzelle C, Reinaud C et al. Exposure during pregnancy to Il-1 targeted therapies and pregnancy, fetal and neonatal outcomes: a study from the French Teratology Information Service. Rheumatology (Oxford). 2025.

Innehållet senast uppdaterat 10/30/2025